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ABSTRACT Salmonella enterica serovars Typhi and Typhimurium cause typhoid fe-
ver and gastroenteritis, respectively. A unique feature of typhoid infection is asymp-
tomatic carriage within the gallbladder, which is linked with S. Typhi transmission.
Despite this, S. Typhi responses to bile have been poorly studied. Transcriptome se-
quencing (RNA-Seq) of S. Typhi Ty2 and a clinical S. Typhi isolate belonging to the
globally dominant H58 lineage (strain 129-0238), as well as S. Typhimurium 14028,
revealed that 249, 389, and 453 genes, respectively, were differentially expressed in
the presence of 3% bile compared to control cultures lacking bile. fad genes, the
actP-acs operon, and putative sialic acid uptake and metabolism genes (t1787 to
t1790) were upregulated in all strains following bile exposure, which may represent
adaptation to the small intestine environment. Genes within the Salmonella patho-
genicity island 1 (SPI-1), those encoding a type IIII secretion system (T3SS), and mo-
tility genes were significantly upregulated in both S. Typhi strains in bile but down-
regulated in S. Typhimurium. Western blots of the SPI-1 proteins SipC, SipD, SopB,
and SopE validated the gene expression data. Consistent with this, bile significantly
increased S. Typhi HeLa cell invasion, while S. Typhimurium invasion was signifi-
cantly repressed. Protein stability assays demonstrated that in S. Typhi the half-life of
HilD, the dominant regulator of SPI-1, is three times longer in the presence of bile;
this increase in stability was independent of the acetyltransferase Pat. Overall, we
found that S. Typhi exhibits a specific response to bile, especially with regard to vir-
ulence gene expression, which could impact pathogenesis and transmission.
KEYWORDS bile responses, cell invasion, H58 clade, RNA-Seq, SPI-1 regulation,
typhoid fever
In humans, the outcome of infection with Salmonella enterica depends primarily onthe infecting serovar; while nontyphoidal, broad-host-range serovars such as Salmo-
nella enterica serovar Typhimurium (S. Typhimurium) cause self-limiting gastroenteritis,
infections with human-restricted typhoidal serovars such as Salmonella enterica serovar
Typhi (S. Typhi) result in typhoid fever (1). The virulence of both serovars depends on
the activity of two type III secretion systems (T3SS) carried on Salmonella pathogenicity
islands 1 and 2 (SPI-1 and SPI-2), which secrete a pool of over 40 effectors to subvert
host cell processes resulting in invasion, immune evasion, and intracellular growth (2).
The SPI-1 T3SS is active when Salmonella is extracellular, and its activity permits
Salmonella invasion of nonphagocytic cells and also promotes early adaptation to the
intracellular environment (2). Expression of the SPI-1 T3SS and its associated genes
(several of which are encoded outside the SPI-1 pathogenicity island) is controlled by
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a hierarchy of regulators (HilD, HilA, HilC, RtsA, InvF). These regulators are controlled by
a variety of factors, including two-component systems, RNA binding proteins, and
global regulators, which respond to a range of environmental stimuli (3, 4).
Typhoid is an acute illness characterized by high fever, malaise, and abdominal pain
(5). S. Typhi causes systemic infection during which the pathogen colonizes the
intestine and mesenteric lymph nodes, the liver, spleen, bone marrow, and gallbladder
(5). It is estimated that there are more than 20 million typhoid fever cases per year,
resulting in more than 200,000 deaths (6). Although with adequate treatment most
patients recover from the acute phase of S. Typhi infection, S. Typhi can persist
asymptomatically within the gallbladder following clinical recovery (7). Overall, 10% of
those infected will carry S. Typhi within their gallbladder for up to 3 months, while 1 to
3% will continue to harbor S. Typhi for longer than 1 year (5, 8). Given the host
restriction of S. Typhi, chronic gallbladder carriage represents a key environmental
reservoir of S. Typhi bacteria, enabling typhoid transmission (7, 9).
Although the exact mechanism(s) by which S. Typhi persists within the gallbladder
are debated (7), it certainly encounters high bile concentrations during carriage, as the
gallbladder is where bile is stored and concentrated prior to secretion into the small
intestine, where it plays a role in the emulsification and absorption of fats (10). In part
due to its detergent activity, bile is also a potent antimicrobial agent (10, 11). However,
enteric pathogens—including Salmonella—are intrinsically resistant to bile (12) and
instead often utilize bile as a means to regulate gene expression and virulence (10, 13).
In S. Typhimurium, expression of the SPI-1 and motility genes is repressed by bile
exposure, resulting in a significant repression of epithelial cell invasion (14, 15).
Despite the importance of asymptomatic carriage, the behavior of S. Typhi within
bile remains poorly understood (7). As the transcriptomic responses of S. Typhimurium
to bile under various conditions have been well characterized (15–18), the behavior of
S. Typhimurium has become an accepted model as to how Salmonella in general
behaves in bile (11, 19). However, a study comparing changes in protein expression by
two-dimensional (2D) gel electrophoresis within S. Typhimurium and S. Typhi following
exposure to 3% bile found that there was “little overlap apparent between proteins
affected by bile in S. Typhi and in S. Typhimurium” (12), suggesting that the response
to bile differs between these serovars. Furthermore, a study comparing the genomes of
S. Typhimurium LT2 and S. Typhi CT18 revealed that less than 90% of genes are shared
between the two strains, with over 600 genes present in CT18 not found in LT2 (20);
therefore, S. Typhimurium cannot be used to model the regulation of S. Typhi-specific
genes, which include key virulence factors such as the Vi antigen and the CdtB and
HlyE/ClyA toxins (20).
The need to better understand S. Typhi infection has been intensified by the recent
spread of haplotype 58 (H58), also known as 4.3.1 (21, 22). Following its emergence
around 30 years ago, S. Typhi strains belonging to haplotype H58 have clonally
expanded worldwide to become the dominant cause of multidrug-resistant (MDR)
typhoid within regions of endemicity (21). As yet, the reasons underlying the relative
success of H58 strains remain unknown.
The aim of this study was to compare the global bile responses of S. Typhi and S.
Typhimurium isolates, which in turn might explain differences in pathogenesis and
reveal processes important for the carrier state.
RESULTS
Bile exposure alters global gene expression in Salmonella. We performed tran-
scriptome sequencing (RNA-Seq) on S. Typhimurium 14028, S. Typhi Ty2, and a clinical
S. Typhi H58 isolate (129-0238) grown in LB to late exponential phase in the presence
or absence of 3% bile. Given the extensive description of S. Typhimurium behavior in
bile (14, 15), S. Typhimurium 14028 was considered a control. For these studies, 3% ox
bile was chosen, as this concentration robustly affects gene expression in S. Typhimu-
rium (14, 15, 23) but does not affect the growth of the investigated Salmonella strains
(see Fig. S1 in the supplemental material). Overall, following growth in bile, 249 and 389
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genes were differentially expressed in S. Typhi Ty2 (182 upregulated; 67 downregu-
lated) and 129-2038 (223 upregulated; 166 downregulated) (Fig. 1), respectively, while
453 genes were differentially regulated in S. Typhimurium 14028 (293 upregulated; 179
downregulated) (Fig. 1).
Gene ontology (GO) enrichment and KEGG pathway analysis on the pools of
upregulated and downregulated genes revealed broad differences between S. Typhi
and S. Typhimurium (Fig. 1). While S. Typhimurium upregulated metabolic processes
and downregulated processes linked with pathogenicity, including T3SS, flagella, and
FIG 1 Comparison of pathways differentially regulated by bile between S. Typhi and S. Typhimurium.
Overrepresented gene ontology (GO) terms within upregulated and downregulated genes following
growth in 3% bile for each strain.
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chemotaxis (motility), in line with previous findings (14, 15, 17), both S. Typhi Ty2 and
129-0238 upregulated these processes, while downregulating various metabolic path-
ways (Fig. 1). KEGG pathway analysis also revealed that fatty acid degradation (repre-
sented by the GO term “fatty acid beta-oxidation”) and tyrosine metabolism were
upregulated in all isolates, implicating these processes in the general Salmonella
response to bile.
Similarities of S. Typhi and S. Typhimurium in their responses to bile. The overlap
in genes either downregulated or upregulated in bile between all strains was small;
only one gene (pagP), a PhoP-PhoQ-regulated gene involved in modifying lipid A (24),
was downregulated in all strains (Fig. 2). Twenty genes were upregulated in all isolates
in response to bile (Fig. 2; Table 1), representing genes involved in tyrosine metabolism,
in sialic acid uptake and utilization (t1787-1790) (25), and in the production of acetyl
coenzyme A (acetyl-CoA) from acetate (actP-acs) and fatty acids (fad genes). Of the
upregulated genes, expression of acs and fadE was validated by quantitative reverse
transcription-PCR (RT-qPCR) (Table 2). Upregulation of sialic acid and acetate metabolic
pathways may reflect adaptation to the small intestine, where these metabolites are
abundant (26), while upregulation of fad genes is consistent with the ability of
Salmonella to utilize phospholipids present in bile as a carbon/energy source (27).
Interestingly, the fatty acid transporter fadL was strongly upregulated in S. Typhimu-
rium but was not upregulated in either S. Typhi Ty2 or 129-0238, suggesting that S.
Typhi may possess additional fatty acid transporters.
Genes implicated in stress responses were also upregulated in bile. All isolates
upregulated msrA, a sulfoxide reductase upregulated in response to oxidative stress,
which is required for growth within macrophages and for full virulence of S. Typhimu-
rium in vivo (28). S. Typhimurium 14028 and S. Typhi 129-0238 also activated RpoS-
mediated stress responses, with upregulation of otsAB, spoVR, yeaG, katE, sodC, poxB,
ecnB, and osmY, in line with previous findings (17, 29, 30). However, upregulation of
these stress-linked genes was not observed in S. Typhi Ty2, which is likely due to a
frameshift mutation within rpoS in this strain (31).
Differences between S. Typhi and S. Typhimurium in their responses to bile. Of
special interest are genes that are regulated differently in response to bile in S. Typhi
and S. Typhimurium. The identification of such genes was achieved by determining
FIG 2 Gene expression in response to bile differs among Salmonella strains. Comparison of genes
upregulated and downregulated in response to bile in S. Typhimurium (Tm), S. Typhi Ty2 (Ty2), and S.
Typhi 129-0238 (H58).
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which genes were downregulated in S. Typhimurium in bile but upregulated in S. Typhi
and vice versa. Of the 75 genes upregulated in both S. Typhi Ty2 and 129-0238 (Fig. 2),
the majority (54/75) were significantly downregulated in S. Typhimurium (Table 3). As
indicated by the GO and KEGG pathway analyses (Fig. 1), genes regulated in this
manner predominantly encode proteins associated with the SPI-1 T3SS or motility. To
validate these findings, expression of the SPI-1-associated genes hilD, hilA, prgH, and
sopB, in addition to the flagellum-associated genes flhD and flgA, was confirmed by
RT-qPCR (Table 2).
Additional genes upregulated in S. Typhi and downregulated in S. Typhimurium
include lpxR (t1208/STM14_1612), a lipid A-modifying protein that modulates the ability
of lipid A to stimulate Toll-like receptor 4 (TLR4) (32) and promotes Salmonella growth
inside macrophages (33), and srfA and srfB, virulence factors expressed under SPI-1-
inducing conditions (34) and reported to modulate inflammatory signaling (35). Addi-
tionally, several hypothetical proteins, t0944 (STM14_2352), t1774 (STM14_1312), and
t2782 (STM14_3479), were upregulated in S. Typhi but downregulated in S. Typhimu-
rium. Given their regulation pattern, these genes may encode uncharacterized viru-
lence factors or be involved in motility in Salmonella.
TABLE 1 Genes upregulated by bile in all strains
Gene name Locus tag Product
Log2 fold change
Tm Ty2 H58
fadI t0475 3-Ketoacyl-CoA thiolase 4.12 2.55 2.52
fadJ t0476 Multifunctional fatty acid oxidation complex
subunit alpha
3.32 2.06 2.17
fadE t2541 Acyl-CoA dehydrogenase 7.44 4.70 4.18
fadB t3315 Multifunctional fatty acid oxidation complex
subunit alpha
7.52 2.92 1.57
fadA t3316 3-Ketoacyl-CoA thiolase 7.66 2.88 1.57
actP t4179 Acetate permease 3.41 1.58 1.27
t4180 Hypothetical protein 3.44 1.72 1.32
acs t4181 Acetyl-CoA synthetase 3.91 2.11 1.31
acnA t1625 Aconitate hydratase 3.18 1.81 1.59
argT t0509 Lysine-arginine-ornithine-binding
periplasmic protein
3.36 2.29 1.33
argD t1182 Bifunctional succinylornithine transaminase/
acetylornithine transaminase
5.61 2.72 1.20
t0677 Gentisate 1,2-dioxygenase 2.51 3.91 3.38
t0678 FAA-hydrolase-family protein 2.09 3.21 2.87
t0679 Glutathione-S-transferase-family protein 2.09 2.89 2.49
t0680 Salicylate hydroxylase 1.27 2.09 2.03
t1787 Oxidoreductase 3.62 3.53 1.32
t1789 Hypothetical protein 3.17 4.04 1.44
t1790 N-Acetylneuraminic acid mutarotase 2.78 4.07 1.32
gabT t2687 4-Aminobutyrate aminotransferase 5.18 2.93 1.74
msrA t4462 Methionine sulfoxide reductase A 1.68 1.67 1.30
TABLE 2 Log2 fold changes ( SD) in gene expression in strains 14028, Ty2, and 129-0238
determined by RNA-Seq and RT-qPCR
Gene
RNA-Seq RT-qPCR
14028 Ty2 129-0238 14028 Ty2 129-0238
hilD 4.08 1.23 3.15 3.48 0.71 1.42 0.25 2.44 0.73
hilA 6.98 1.54 3.67 6.51 0.64 1.71 0.39 3.37 0.39
prgH 6.36 1.57 4.02 6.00 0.74 1.68 0.73 4.00 0.48
sopB 6.95 1.11 4.21 3.85 0.44 1.38 0.59 4.13 0.27
flhD 1.72 1.05 1.33 1.25 0.43 1.93 0.38 2.31 1.13
flgA 1.29 1.37 1.70 0.98 0.27 1.99 0.44 1.37 0.84
fadE 7.44 4.70 4.18 3.55 2.13 3.75 0.16 4.75 0.09
acs 3.91 2.11 1.31 2.03 1.77 0.87 0.67 2.37 0.59
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We also analyzed the expression profile of S. Typhi-specific genes. S. Typhi Ty2
carries 453 unique genes relative to S. Typhimurium, representing Ty2 homologues of
the 601 S. Typhi-specific genes identified in CT18 (36), in addition to 29 Ty2-specific
genes (37). Only two of these genes were significantly regulated by bile exposure in
TABLE 3 Genes downregulated in S. Typhimurium and upregulated in S. Typhi in bile
Gene name Locus tag Product
Log2 fold change
Tm Ty2 H58
fliO t0899 Flagellar biosynthesis protein FliO 1.87 1.57 1.35
fliN t0900 Flagellar motor switch protein FliN 1.55 1.44 1.62
fliM t0901 Flagellar motor switch protein FliM 1.71 1.40 1.71
fliL t0902 Flagellar basal body protein FliL 1.74 1.41 1.78
fliK t0903 Flagellar hook length control protein 1.67 1.33 2.08
fliJ t0904 Flagellar biosynthesis chaperone 1.37 1.43 2.25
fliI t0905 Flagellum-specific ATP synthase 1.43 1.25 1.69
fliH t0906 Flagellar assembly protein H 1.45 1.41 1.57
fliG t0907 Flagellar motor switch protein G 1.44 1.34 1.53
fliF t0908 Flagellar MS-ring protein 1.89 1.32 1.41
fliE t0909 Flagellar hook basal body protein FliE 2.49 1.76 2.01
flhD t0952 Transcriptional activator FlhD 1.72 1.05 1.33
flgJ t1738 Flagellar rod assembly protein/muramidase FlgJ 1.56 1.30 1.38
flgI t1739 Flagellar basal body P-ring biosynthesis protein FlgA 1.69 1.41 1.39
flgH t1740 Flagellar basal body L-ring protein 1.71 1.42 1.68
flgC t1745 Flagellar basal body rod protein FlgC 1.86 1.39 1.79
flgB t1746 Flagellar basal body rod protein FlgB 2.05 1.40 1.73
flgA t1747 Flagellar basal body P-ring biosynthesis protein FlgA 1.29 1.37 1.70
sprB t2768 AraC family transcriptional regulator 3.76 1.97 4.11
sprA t2769 AraC family transcriptional regulator 3.29 1.97 3.29
t2770 Hypothetical protein 3.69 1.22 2.11
orgA t2771 Oxygen-regulated invasion protein 3.90 1.34 1.79
orgA t2772 Oxygen-regulated invasion protein 5.65 1.62 3.50
prgJ t2774 Pathogenicity island 1 effector protein 6.05 1.43 3.83
prgI t2775 Pathogenicity island 1 effector protein 6.15 1.41 3.89
prgH t2776 Pathogenicity island 1 effector protein 6.36 1.57 4.02
hilA t2778 Invasion protein regulator 6.98 1.54 3.67
iagB t2779 Cell invasion protein 6.64 1.35 3.83
sicP t2781 Chaperone 3.06 1.40 3.19
t2782 Hypothetical protein 3.10 1.56 2.98
sipF or iacP t2783 Acyl carrier protein 5.62 1.46 3.43
sipA t2784 Pathogenicity island 1 effector protein 5.84 1.55 3.60
sipD t2785 Pathogenicity island 1 effector protein 6.24 1.48 3.87
spaS t2789 Surface presentation of antigens protein SpaS 5.70 1.24 3.29
spaQ t2791 Virulence-associated secretory protein 7.26 1.40 3.00
spaP t2792 Surface presentation of antigens protein SpaP 6.87 1.43 3.25
spaO t2793 Surface presentation of antigens protein SpaO 6.72 1.60 3.66
spaN t2794 Antigen presentation protein SpaN 6.66 1.58 3.91
spaM t2795 Virulence-associated secretory protein 6.91 1.76 3.83
spaL or invC t2796 ATP synthase SpaL 6.61 1.53 3.43
spaK or invB t2797 Virulence-associated secretory protein 6.04 1.91 4.01
invA t2798 Virulence-associated secretory protein 6.50 1.40 3.34
invE t2799 Cell invasion protein 6.86 1.35 3.59
invG t2800 Virulence-associated secretory protein 7.12 1.37 3.60
invF t2801 AraC family transcriptional regulator 6.97 1.27 3.84
invH t2802 Cell adherence/invasion protein 4.54 1.57 2.97
sopD t2846 Hypothetical protein 3.76 1.05 4.33
rtsB t4220 GerE family regulatory protein 7.59 1.99 3.58
rtsA t4221 AraC family transcriptional regulator 7.33 1.80 3.83
t0944 Lipoprotein 2.25 1.20 2.22
t1774 Hypothetical protein 2.09 1.46 2.60
lpxR t1208 Hypothetical protein 7.02 1.19 3.44
srfA t1503 Virulence effector protein 1.75 1.64 1.81
srfB t1504 Virulence effector protein 1.48 1.58 1.88
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both S. Typhi Ty2 and 129-0238. Both genes, which are upregulated in bile, encode
hypothetical proteins: t0349 (STY2749) encodes a GIY-YIG domain containing protein,
and t1865 (STY1076) encodes a homologue of the NleG family of T3SS effectors (38, 39).
Neither S. Typhi isolate demonstrated altered expression of genes encoding the Vi
antigen or of the typhoid toxin in bile.
Bile influences SPI-1 expression and Salmonella invasion. The most marked differ-
ences between S. Typhi and S. Typhimurium in response to bile was in the expression
of SPI-1-associated genes. The majority of genes within the SPI-1 pathogenicity island,
in addition to the SPI-1 regulators rtsA and rtsB, and effector genes carried outside SPI-1
(sopD) were significantly upregulated in S. Typhi Ty2 and 129-0238 but significantly
downregulated in S. Typhimurium (Table 3; Fig. 3A). Noticeably, S. Typhi 129-0238
exhibited significantly elevated expression of SPI-1 genes relative to S. Typhi Ty2 (Table
3; Fig. 3A).
To determine if changes in SPI-1 gene expression correlated with changes at the
protein level, we compared the intracellular levels of the SPI-1 translocon proteins SipC
and SipD and the SPI-1 effectors SopE (for S. Typhi) or SopB (for S. Typhi and S.
Typhimurium) from each strain grown in the absence or presence of bile. Additional S.
FIG 3 Effects of bile on SPI-1 expression and activity. (A) Heatmap showing log2-fold changes in gene expression for S. Typhimurium (Tm), S. Typhi Ty2 (Ty2),
and S. Typhi 129-0238 (H58) across the SPI-1 pathogenicity island and for non-SPI-1-carried effectors. Asterisks (*) indicate genes significantly affected by bile
across all three strains. (B) Western blots of SipC, SipD, and SopE of S. Typhimurium 14028 (Tm), S. Typhi Ty2 (Ty2), and two H58 clinical isolates (ERL12148 and
129-0238) grown in LB with or without 3% bile; SopE panels are not shown for S. Typhimurium 14028, as this strain lacks SopE. DnaK was used as a loading
control. A representative blot for two independent repeats is shown. Numbers below blots indicate fold changes in density in 3% bile compared to LB; all bands
were normalized to their respective DnaK control prior to comparison. (C) Strains grown in LB or 3% bile to late exponential phase were added to HeLa cells
at an MOI of 100 for 30 min. The percentages of intracellular bacteria at 2 h postinfection relative to the inoculum added are shown. n  3; error bars show
SD. Invasion rates of strains were compared by t test (**, P  0.01; ***, P  0.001).
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Typhi strains were also included to further expand and validate these findings, namely,
the RpoS S. Typhi reference strain CT18 (37) and an additional H58 isolate, strain
ERL12148, which belongs to a different sublineage of H58 from that of 129-0238 (21).
All S. Typhi strains tested (Ty2, CT18, 129-0238, ERL12148) showed increased levels of
SPI-1 proteins, with the H58 strains demonstrating the largest increases in SPI-1 protein
expression in bile (Fig. 3B; see also Fig. S2 in the supplemental material). Conversely, S.
Typhimurium 14028 showed decreased levels of SopB, SipD, and SipC following growth
in bile (Fig. 3B and S2); as S. Typhimurium 14028 lacks SopE, its lanes (Tm) in the SopE
blot are not shown.
Given the significant effect of bile on SPI-1 expression, we investigated the impact
of bile on epithelial cell invasion. In line with previous findings (14), S. Typhimurium
exposed to bile demonstrated significantly reduced invasion, achieving an invasion rate
approximately 90% lower than that of S. Typhimurium grown in the absence of bile
(Fig. 3C). In contrast, all S. Typhi strains tested demonstrated significantly increased
invasion following bile exposure, with Ty2 and CT18 displaying an approximate 2-fold
increase in the number of intracellular bacteria at 2 h postinfection and both H58
isolates demonstrating even higher increases in invasion (between 4- and 16-fold
greater) (Fig. 3C and S2). An SPI-1-deficient strain of S. Typhi Ty2 (ΔinvA) did not invade
HeLa cells in the presence of bile, indicating that the increased invasiveness of S. Typhi
in bile is SPI-1 dependent (Fig. S2).
Transcriptional regulation of SPI-1 regulators in bile. Given the striking differ-
ence in SPI-1 expression between S. Typhi and S. Typhimurium in response to bile, we
determined where and how SPI-1 regulation differs between the two serovars. The
central regulators governing SPI-1 expression are HilA, often termed the master SPI-1
regulator, and HilD, which is the dominant regulator of HilA (3, 40). The RNA-Seq and
RT-qPCR data show that the mRNA levels of these regulators significantly decrease in
S. Typhimurium in response to bile but significantly increase in response to bile in the
S. Typhi strains (Table 2).
In order to determine if these changes are mediated by transcriptional regulation of
these genes, we constructed hilA and hilD lacZ chromosomal transcriptional reporters
in S. Typhimurium 14028 and S. Typhi Ty2 (41). The reporter activity was determined by
-galactosidase assay following growth to late exponential phase in LB with or without
3% bile. In S. Typhimurium, expression of hilA was significantly reduced in the presence
of bile, with expression almost 20-fold lower, while expression of hilD was unchanged
(Fig. 4). In contrast, expression of hilA in S. Typhi significantly increased in bile, with
expression over 3 times higher, while hilD expression was only modestly increased (Fig.
4). Taken together, these results indicate that hilA is transcriptionally regulated by bile
in both S. Typhi and S. Typhimurium, while hilD is not subject to transcriptional
regulation.
The seeming absence of hilD transcriptional regulation in bile (Fig. 4) is at odds with
the significant changes in mRNA levels observed (Table 2). One explanation is that
hilD::lacZ reporter strains do not account for HilD-mediated autoregulation, as the
chromosomal reporter strains were made in a ΔhilD background. HilD autoregulation
has previously been reported in S. Typhimurium (42) but has not been characterized in
S. Typhi. To determine if HilD autoregulation could account for transcriptional changes
of hilD in bile in S. Typhi, the hilD::lacZ S. Typhi Ty2 reporter strain was transformed with
a plasmid expressing HilD or an empty vector control, and reporter activity was
assessed by -galactosidase assay following growth in LB. hilD expression from the
strain complemented with HilD was significantly higher than hilD expression from both
the reporter strain alone and the reporter carrying the empty vector (Fig. 5), indicating
that in S. Typhi HilD positively regulates its own transcription, either directly or
indirectly.
Bile influences HilD stability. Given that expression of hilA, a gene directly regu-
lated by HilD, significantly increases in bile, we investigated if HilD is posttranscription-
ally regulated by bile in S. Typhi. Previous studies have shown that in S. Typhimurium,
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HilD stability is markedly decreased in the presence of bile, with a reported half-life
almost 4 times shorter in LB supplemented with 3% bile than in LB alone (23). To
determine the effect of bile on HilD stability in S. Typhi, S. Typhi Ty2 was transformed
with constitutively expressed hemagglutinin (HA)-tagged HilD (from S. Typhi Ty2) and
subcultured in the presence or absence of bile, and samples were taken at regular
intervals following the inhibition of protein synthesis. Importantly, the HA-tagged HilD
used in these studies was functional (Fig. 5), indicating that the HA tag used does not
FIG 4 Effects of bile on hilA and hilD transcription in Salmonella. The reporter activity (-galactosidase
units) of hilA::lacZ and hilD::lacZ in S. Typhimurium 14028 (A, B) and S. Typhi Ty2 (C, D) following growth
to late exponential phase in LB in the presence or absence of bile. n  3; error bars show SD. Reporter
activity between strains was compared by t test (*, P  0.05; ***, P  0.001).
FIG 5 HilD autoregulation in S. Typhi. The reporter activity of an S. Typhi Ty2 hilD::lacZ chromosomal
transcriptional reporter strain complemented with HilD (pWSK29-Spec HilD-4HA [HilD]) or an empty
vector control (pWSK29-Spec [EV]) was determined by -galactosidase assay following growth in LB. n 
3; error bars show SD. Reporter activity between strains was compared by one-way ANOVA (***, P 
0.001).
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disrupt HilD structure or activity. In LB the half-life of HilD was 14 min, while in bile the
half-life of HilD increased to 40 min, indicating that HilD is approximately three times
more stable in the presence than in the absence of bile in S. Typhi (Fig. 6A).
HilD is highly conserved between S. Typhi and S. Typhimurium (99% identity; 2
amino acid changes). Since HilD has previously been shown to be less stable in bile in
S. Typhimurium (23), we next determined if this difference in stability was due to
intrinsic differences between HilD between the serovars or rather due to differences in
factors that act on HilD and influence its stability. To investigate this, we determined
the stability of HA-tagged HilD from S. Typhimurium 14028 expressed in S. Typhi Ty2.
As was observed for S. Typhi HilD, S. Typhimurium HilD was three times more stable in
bile, with a recorded half-life increasing from 8 min in LB to 21 min (Fig. 6B).
Although several factors have been reported to posttranscriptionally regulate HilD
(e.g., HilE, CsrA, GreE/GreB, FliZ, Hfq, RNase E [3, 43, 44]), only two have been described
to directly influence HilD protein stability: the protease Lon, which degrades HilD (45),
and the acetyltransferase Pat, which acetylates HilD to increase stability while decreas-
ing DNA binding (46). To determine if these factors were involved in mediating HilD
FIG 6 Bile promotes HilD stability in S. Typhi. WT S. Typhi Ty2 constitutively expressing C-terminally
4HA-tagged HilD from S. Typhi Ty2 (A) or S. Typhimurium 14028 (B) was grown in LB with or without bile.
Thirty micrograms per milliliter chloramphenicol was added to stop protein synthesis, and samples were
collected every 10 min. HilD levels were determined via Western blotting using an anti-HA antibody, and
DnaK was used as a loading control. A representative blot for three independent repeats is shown.
Half-life measurements are averaged from three independent repeats, and standard deviations are
shown.
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stability in bile in S. Typhi Ty2, deletions were constructed and HilD stability was
determined as described previously. Unfortunately, a Δlon Ty2 strain had severe growth
defects and could not be tested. Although HilD stability was decreased in a Δpat Ty2
strain, in line with previous findings in S. Typhimurium (46, 47), it was still increased in
the presence of bile, increasing from 4 min in LB to 13 min in the presence of bile (see
Fig. S3 in the supplemental material), indicating that Pat-mediated acetylation of HilD
is not responsible for the increased stability in bile. Overall, our data suggest that
factors responsible for governing the stability of HilD in response to bile (other than
Pat) differ between S. Typhi and S. Typhimurium.
DISCUSSION
Transcriptomic analysis of S. Typhimurium and S. Typhi strains grown in LB or 3%
bile permitted the identification of similarities and differences in each serovar’s re-
sponse to bile. Significant differences were observed in the regulation of the invasion-
associated SPI-1 T3SS and in motility genes between nontyphoidal and typhoidal
serovars. S. Typhi strains significantly upregulated these processes and displayed a
significant increase in T3SS-dependent invasion in bile, a response akin to that of other
enteric pathogens (13), including Vibrio parahaemolyticus (48), Vibrio cholerae (49, 50),
and Shigella (51, 52). All S. Typhi strains tested (Ty2, CT18, and two H58 clinical isolates)
demonstrated significantly increased invasion in bile, strongly suggesting that this is a
common response of S. Typhi to bile.
It is interesting to consider why S. Typhi and S. Typhimurium have such disparate
responses to bile. During infection, Salmonella encounters bile within the small intes-
tine and, in the case of S. Typhi, within the gallbladder. Following the observation that
S. Typhimurium invasion was significantly repressed in the presence of bile (14), a
model was proposed that S. Typhimurium uses bile concentration as a means to sense
proximity to the intestinal epithelium; in the lumen, where bile concentration is
highest, SPI-1 expression would be repressed, and as the bacteria get closer to the
intestinal cells, bile concentration would decrease, leading to SPI-1 expression and
invasion (14). Within the context of this model, however, S. Typhi would be less invasive
when in close contact with the intestinal epithelium, which is consistent with the
limited intestinal inflammatory responses induced by S. Typhi (1). Moreover, S. Typhi
has a unique site of infection, the gallbladder (7, 9). One of the mechanisms by which
S. Typhi has been proposed to persist within the gallbladder is via direct invasion of
gallbladder epithelial cells (53, 54); bile-induced increases in SPI-1 expression and
invasiveness may therefore promote S. Typhi invasion and colonization of the gallblad-
der epithelium. Alternatively, as S. Typhi carriage is closely associated with the presence
of gallstones, it is believed that S. Typhi forms biofilms on gallstone surfaces (7, 55).
Biofilm formation on gallstones depends on several factors, including the presence of
flagellar filaments (56); thus, increased flagellar expression may therefore also promote
biofilm formation. As such, increases in expression of SPI-1- and motility-associated
genes in bile may promote S. Typhi colonization of the gallbladder and therefore reflect
adaptation to this environment.
In terms of understanding how S. Typhi and S. Typhimurium differ with regard to
SPI-1 expression in bile, our results, in combination with previous findings (23), dem-
onstrate that HilD is differentially regulated by bile at the level of protein stability
(consistent with the idea that HilD is controlled largely at the posttranscriptional level
[40]), resulting in significant differences in the expression of downstream genes,
including the SPI-1 master regulator, hilA (Fig. 7). The factor(s) responsible for mediating
changes in HilD stability in response to bile remains to be established; however, this
response does not appear to rely on Lon (23) or Pat (this study). A recent transposon
screen that aimed to identify factors responsible for bile-mediated SPI-1 repression in
S. Typhimurium failed to identify any regulatory factor other than HilD (23). There are
several reasons why such an approach may have failed, including the involvement of
essential genes or redundancy. Unfortunately, attempts to further identify regulatory
mechanisms in S. Typhi are confounded by the limited characterization of SPI-1-
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regulatory processes within S. Typhi. The overall effects of bile on differences in
invasiveness between S. Typhi and S. Typhimurium may also not be entirely regulatory;
for example, the translocon protein SipD has been reported to interact with bile salts
(57), but SipD is one of several T3SS-associated proteins reported to be “differentially
evolved” (as determined by nonsynonymous amino acid changes) between typhoidal
and nontyphoidal serovars, which results in functional differences (58). Importantly, in
Shigella flexneri, interaction of deoxycholate or other bile salts with the SipD homo-
logue, IpaD, promotes the recruitment of the translocator protein, IpaB, “readying” the
T3SS for secretion (59, 60).
Our results also demonstrate that strains belonging to the S. Typhi H58 lineage
(129-0238 and ERL12148) display significantly increased responses to bile compared to
S. Typhi reference strains (Ty2 and CT18). When considering chronic carriage, such
responses may be advantageous by increasing the potential of H58 strains to colonize
the gallbladder, increasing bacterial burden, and subsequently increasing transmission.
However, it is currently unknown if this reflects differences between recently isolated
clinical strains and more-laboratory-adapted reference strains or is instead due to
intrinsic difference in H58 strains compared to other S. Typhi haplotypes. H58 isolates
have 44 nonsynonymous single nucleotide polymorphisms (SNPs) that are not found
within the S. Typhi reference strain CT18 (21), including several SNPs within the Csr
system (sirA [L63F], csrB [155GA], csrD [A620V]), which is a known regulator of SPI-1
(61). Interestingly, significant phenotypic differences in bile were also observed be-
tween the two H58 strains investigated. Further comparisons of H58 strains would be
required to determine if the phenotypic differences observed are sublineage specific or
simply reflect diversity within the H58 group.
In conclusion, our results confirm that bile is a key regulator of gene expression in
Salmonella, influencing the expression of almost 10% of the genome, including genes
associated with virulence, motility, and metabolism. These findings add to the charac-
terization of S. Typhi responses to bile (30, 62), which may ultimately help explain the
mechanisms by which S. Typhi induces chronic carriage (13).
MATERIALS AND METHODS
Bacterial strains, growth conditions, and plasmid construction. The strains and plasmids used in
this study are listed in Table 4. Salmonella cells were routinely grown in LB Lennox (Sigma-Aldrich) at
37°C/200 rpm. Ox bile (3%, wt/vol; Sigma-Aldrich/Merck-Millipore) was supplemented as indicated.
All oligonucleotides used in this study are listed in Table S1 in the supplemental material. The S. Typhi
Ty2 ΔinvA and Δpat deletion strains were constructed via lambda red, as previously described (63, 64).
FIG 7 Proposed model of how bile influences SPI-1 expression in S. Typhi. (A) HilD is at the top of the
SPI-1-regulatory hierarchy, where it regulates its own expression and the expression of HilA. HilD also regulates
expression of the additional regulators HilC and RtsA, which also control HilA expression. (B) In the absence of bile,
the turnover of HilD is high and the expression of hilD is at a basal level, and as a result the expression of hilA is
low. (C) In the presence of bile, HilD is more stable, leading to enhanced expression of hilD, hilA, and thus SPI-1.
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Strains with chromosomal integration of the lacZ gene were also constructed via lambda red recombi-
nation as described previously (41). Correct integration of introduced cassettes was validated by PCR.
To create HA-tagged HilD, pWSK29-Spec-4HA (64) was amplified with a reverse primer containing a
PacI digestion site, and HilD was amplified from both S. Typhimurium and S. Typhi with primers
containing NotI and PacI restriction sites. Both products were digested, and HilD was cloned into the
existing NotI site and the introduced PacI site of pWSK29-Spec-4HA, resulting in constitutively expressed
C-terminally tagged HilD-4HA. Plasmid construction was validated by sequencing.
Cell culture and HeLa invasion assays. HeLa cells (ATCC) were maintained in Dulbecco’s modified
Eagle medium supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich) in 5% CO2 at 37°C. The
cells were authenticated via short tandem repeat profiling in February 2016 (Microsynth).
Invasiveness of strains was determined by gentamicin protection assays, as previously described (64).
Briefly, Salmonella strains were cultured overnight at 37°C/200 rpm in LB or LB supplemented with 3%
bile before subculturing 1:33 in LB or LB–3% bile until late exponential phase (optical density at 600 nm
[OD600], 1.8), when SPI-1 expression is induced (18) (data not shown). To prevent bile-mediated cell
lysis, bacteria were washed twice in LB before addition to cells at a multiplicity of infection (MOI) of 100:1.
As S. Typhi is less invasive than S. Typhimurium (65), S. Typhi infections were performed for 1 h and S.
Typhimurium infections for 15 min, prior to the addition of gentamicin, unless otherwise indicated. At
indicated time points, cells were lysed, serially diluted, and plated to enumerate intracellular CFU.
RNA extraction. Salmonella was cultured overnight in LB or LB supplemented with 3% bile (wt/vol)
before subculturing 1:33 until late exponential phase (OD600, 1.8). Bacteria (6 	 108) were incubated
in RNAprotect (Qiagen) at room temperature (RT) for 5 min. Bacteria were digested with lysozyme (15
mg/ml) and proteinase K for 20 min at RT, and RNA was extracted using the RNeasy minikit (Qiagen) as
per the manufacturer’s instructions. RNA extractions for transcriptome sequencing (RNA-Seq) were
performed in duplicate, and then the RNAs samples were pooled over three biological repeats. RNA
extractions for quantitative reverse transcription-PCR (RT-qPCR) were performed in triplicate over three
biological repeats. RNA samples for RNA-Seq and RT-qPCR were extracted independently of each other.
RNA sequencing and data analysis. For RNA sequencing, mRNA libraries were multiplexed and
prepared by utilization of the Illumina TruSeq protocol followed by sequencing via paired-end meth-
odology on the Illumina HiSeq version 4 platform. Each lane of Illumina sequence was assessed for
quality on the basis of adapter contamination, average base read quality, and any unusual G-C bias using
FastQC. The median Phred score for all samples was 34. To permit comparison between strains,
sequenced reads for each strain were mapped to the Ty2 genome (NC_004631) using the Rockhopper
tool (66) with default parameters (see Data Sets S1 to S3 in the supplemental material). The read
alignment coverage for each sample can be found in Table S2 in the supplemental material. The
threshold for differentially expressed genes was gated as those displaying 2-fold change in expression
in 3% bile compared to LB alone and with an adjusted P value (q value) of 0.05.
GO term enrichment for differentially regulated genes was performed with Panther (67) using the S.
Typhimurium GO annotation, while KEGG pathway analysis was performed with the GAGE R package (R
3.3.1) (68), using the S. Typhi (stt) KEGG annotation. The VennDiagram (69) and gplots R packages were
used for data visualization.
TABLE 4 Strains and plasmids used in this study
Strain or plasmid (identifier) Relevant genotype or comments
Source and/or
reference
Strains
S. Typhimurium
14028 (ICC797) WT 64
14028 (ICC1765) ΔhilA::lacZ Kanr This study
14028 (ICC1764) ΔhilD::lacZ Kanr This study
S. Typhi
Ty2 (ICC1500) WT G. Dougan
Ty2 (ICC1630) ΔhilA::lacZ Kanr This study
Ty2 (ICC1762) ΔhilD::lacZ Kanr This study
Ty2 (ICC1556) ΔinvA Kanr 64
Ty2 (ICC1756) Δpat Kanr This study
CT18 (ICC1502) WT G. Dougan
129-0238 (ICC1503) WT, H58 isolate G. Dougan (21)
ERL12148 (ICC1504) WT, H58 isolate G. Dougan (21)
Plasmids
pKD4 (pICC893) Kanamycin cassette template plasmid 63
p3138 (pICC2515) LacZ and kanamycin cassette template
plasmid
41
pKD46 (pICC1298) Lambda red recombinase plasmid 63
pWSK29-Spec E.V. (pICC2489) Empty vector, spectinomycinr 64
pWSK29-Spec HilD-4HA Ty2 S. Typhi Ty2 HilD-4HA, constitutive promoter This study
pWSK29-Spec HilD 4HA Tm S. Typhimurium 14028 HilD-4HA, constitutive
promoter
This study
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RT-qPCR. For RT-qPCR, 2 g of RNA was treated with DNase (Promega) prior to reverse transcription
with Moloney murine leukemia virus (MMLV) reverse transcriptase (Promega) according to the manu-
facturer’s recommendations. The Fast SYBR green master mix (Applied Biosystems) was used for qPCRs
alongside the Applied Biosystems StepOnePlus system. Twenty nanograms of cDNA was used per
reaction mixture, and forward and reverse primers (Table S1) were used at a final concentration of 0.2
M. Samples without reverse transcription were included as negative controls. The housekeeping gene
ftsZ was used as the reference gene, as it was determined to be the least-variable gene between strains
and between culture conditions of LB with and without 3% bile. qPCRs were performed in duplicate on
triplicate samples over three biological replicates.
SPI-1 protein expression and stability assays. To determine expression of SPI-1 proteins, Salmo-
nella was subcultured in the absence or presence of 3% ox bile to late exponential phase. One milliliter
of culture was pelleted and resuspended in 2	 SDS loading buffer (1 M Tris [pH 6.8], 2% SDS, 20%
glycerol, 5% -mercaptoethanol, bromophenol blue) in proportion to OD600. To determine HilD stability,
Salmonella strains previously transformed with 4HA-tagged constructs were subcultured in 10 ml LB with
or without the addition of 3% ox bile until late exponential phase. The OD600 was recorded, and
chloramphenicol (30 g/ml) was added to inhibit protein synthesis. Bacteria (1 ml) were pelleted and
resuspended in 2	 SDS loading buffer in proportion to OD600. The cultures were incubated at 37°C
and 200 rpm, and 1-ml samples were taken at required time points. Samples were heated at 95°C
for 10 min. Whole-cell samples were subjected to Western blotting, using an anti-HA antibody to
detect the protein of interest and DnaK as a loading control. Following imaging, band density was
quantified using ImageJ, and half-life (in minutes) was calculated using the equation [t 	 ln(2)]/
[ln(N0/Nf)], where t is the time elapsed between measurements (in minutes), N0 is the initial amount,
and Nf is the final amount (23). To determine changes in SPI-1 proteins in bile, band density was
quantified using ImageJ, levels of SPI-1 proteins were normalized to the corresponding DnaK value,
and fold changes in bile relative to LB were calculated.
SDS-PAGE and Western blotting. Proteins were separated on 12% acrylamide gels followed by
semidry transfer onto polyvinylidene difluoride (PVDF) membranes (GE Healthcare). Membranes were
blocked in 5% milk in phosphate-buffered saline (PBS)–0.05% Tween 20 (Sigma-Aldrich) and probed with
either anti-DnaK 8E2/2 (1:10,000; Enzo Life Sciences catalog number ADI-SPA-880), anti-HA HA-7 (1:1,000;
Sigma catalog number H3663), anti-SipC, anti-SipD, anti-SopB, or anti-SopE (1:5,000; V. Koronakis,
University of Cambridge) primary antibodies, followed by horseradish peroxidase (HRP)-conjugated
secondary antibody (1:10,000; Jackson ImmunoResearch). Chemiluminescence following the addition of
EZ-ECL reagent (Geneflow) was detected using the LAS-3000 imager (Fuji).
-Galactosidase assays. -Galactosidase assays were performed as previously described (70).
Salmonella strains were grown under SPI-1-inducing conditions with or without the addition of 3% ox
bile. The OD600 was recorded, and 1 ml of culture was pelleted and resuspended in 1 ml Z buffer (0.06
M Na2HPO4, 0.04 M NaH2PO4, 0.01 M KCl, 0.001 M MgSO4, and 0.05 M -mercaptoethanol, pH 7).
Wild-type (WT) strains were used as negative controls. Samples were permeabilized with the addition of
0.1% SDS and chloroform and vortexed for 2 min. Twenty microliters of prepared sample was added to
180 l Z buffer in a 96-well microplate, and 2-nitrophenyl -D-galactopyranoside (ONPG) substrate (4
mg/ml in Z buffer) was added. Plates were incubated at RT, and then the reaction was stopped with the
addition of 1 M Na2CO3. The absorbance of the samples was measured at 405 nm and 540 nm using a
FLUOStar Omega plate reader (BMG Labtech).
Statistical analysis. Statistical tests were performed using GraphPad Prism (version 7.00) for Win-
dows (GraphPad Software, San Diego, CA, USA). All data are expressed as means  standard deviations
(SD). Significance (P  0.05) was determined by unpaired t test or analysis of variance (ANOVA), with
correction for multiple comparisons when required.
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